Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Techne Corp - Common Stock (NQ: TECH )

75.83 -0.27 (-0.35%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 990,971
Open 77.01
Bid (Size) 74.35 (1)
Ask (Size) 75.83 (1)
Prev. Close 76.10
Today's Range 75.66 - 77.17
52wk Range 61.16 - 85.57
Shares Outstanding 158,891,800
Dividend Yield 0.42%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks Rise On Core Inflation Slowdown, Banks Rally After Strong Q4 Earnings, Treasury Yields Plummet
Major indices rallied on Wednesday after December inflation data showed underlying price pressures slowing, reducing fears of a prolonged pause in interest rate cuts by the Federal Reserve. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Markets Breathe Sigh Of Relief After In-Line Inflation Data: Stocks Rebound As Small Caps, Bonds Soar
October inflation data meets expectations with a slight uptick in annual rate, core inflation steady at 3.3%. Fed may cut rates in Dec. Market reacts positively. 
Via Benzinga
Topics Economy
Exposures Interest Rates

Performance

YTD
+6.09%
+6.09%
1 Month
+4.25%
+4.25%
3 Month
+7.77%
+7.77%
6 Month
-2.49%
-2.49%
1 Year
+5.29%
+5.29%

More News

Read More
A Look Ahead: Bio-Techne's Earnings Forecast
Via Benzinga
Deep Dive Into Bio-Techne Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
Demystifying Bio-Techne: Insights From 4 Analyst Reviews
Via Benzinga
Navigating 4 Analyst Ratings For Bio-Techne
Via Benzinga
Bio-Techne: Commitment to Investor Contentment with Steadfast Earnings Performance
Via Benzinga
Warner Bros, Airbnb And Monster Beverage Are Among Top 10 Large Cap Losers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
Via Benzinga
TECH Stock Earnings: Bio-Techne Meets EPS, Misses Revenue for Q4 2024
Via InvestorPlace
3 Genomics Stocks That May Transform Personalized Medicine
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Earnings Outlook For Bio-Techne
Via Benzinga
7 Cheap Biotech Stocks With Major Upside Potential
Via InvestorPlace
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
Via InvestorPlace
5 Stocks At The Forefront Of S&P 500 ETF's Latest Rally
Via Talk Markets
Topics ETFs Stocks
Exposures US Equities
Which Large-Cap Stocks Are Winning This Earnings Season? 15 Stocks To Watch (April 28-May 4, 2024)
Via Benzinga
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
TECH Stock Earnings: Bio-Techne Beats EPS, Beats Revenue for Q3 2024
Via InvestorPlace
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
Via InvestorPlace
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
Via InvestorPlace
Bio-Techne: Bolstering Investor Value with Reduced Dividends and Amplified Earnings
Via Benzinga
The 3 Best Biotech Stocks to Buy in February 2024
Via InvestorPlace
RBC Capital Maintains Sector Perform Rating for Bio-Techne: Here's What You Need To Know
Via Benzinga
Earnings Scheduled For February 1, 2024
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.